BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhao YL, Meng ZD, Xu ZY, Guo JJ, Chai SA, Duo CG, Wang XY, Yao JF, Liu HB, Qi SX, Zhu HB. H2 strain attenuated live hepatitis A vaccines: Protective efficacy in a hepatitis A outbreak. World J Gastroenterol 2000; 6(6): 829-832 [PMID: 11819704 DOI: 10.3748/wjg.v6.i6.829]
URL: https://www.wjgnet.com/1007-9327/full/v6/i6/829.htm
Number Citing Articles
1
Raymond S Koff. Hepatitis vaccines: recent advancesInternational Journal for Parasitology 2003; 33(5-6): 517 doi: 10.1016/S0020-7519(03)00065-1
2
Pierre Van Damme, Rosa M. Pintó, Zongdi Feng, Fuqiang Cui, Angela Gentile, Daniel Shouval. Hepatitis A virus infectionNature Reviews Disease Primers 2023; 9(1) doi: 10.1038/s41572-023-00461-2
3
Ning-Zhu Hu, Yun-Zhang Hu, Hai-Jing Shi, Guo-Dong Liu, Su Qu. Mutational characteristics in consecutive passage of rapidly replicating variants of hepatitis A virus strain H2 during cell culture adaptationWorld Journal of Gastroenterology 2002; 8(5): 872-878 doi: 10.3748/wjg.v8.i5.872
4
J. Luo, X. Wang, F. Ma, G. Kang, Z. Ding, C. Ye, Y. Pan, Y. Zhao, S. Hong, J. Chen, J. Xi, S. Wen, Y. Lin, X. Li, L. Qiu, X. Yang, G. Li, J. Yang, Q. Sun. Long-term immunogenicity and immune persistence of live attenuated and inactivated hepatitis a vaccines: a report on additional observations from a phase IV studyClinical Microbiology and Infection 2019; 25(11): 1422 doi: 10.1016/j.cmi.2018.11.005
5
Christian Herzog, Koen Van Herck, Pierre Van Damme. Hepatitis A vaccination and its immunological and epidemiological long-term effects – a review of the evidenceHuman Vaccines & Immunotherapeutics 2021; 17(5): 1496 doi: 10.1080/21645515.2020.1819742
6
Nick M. Walsh, Heidi M. Soeters, Noele P. Nelson, Yury Khudyakov, Mark K. Weng. Plotkin's Vaccines2023; : 365 doi: 10.1016/B978-0-323-79058-1.00026-8
7
Yuri Y. Kusov, Natalja A. Zamjatina, Valentina F. Poleschuk, Michail I. Michailov, Graziella Morace, Josef Eberle, Verena Gauss-Müller. Immunogenicity of a chimeric hepatitis A virus (HAV) carrying the HIV gp41 epitope 2F5Antiviral Research 2007; 73(2): 101 doi: 10.1016/j.antiviral.2006.08.003
8
Nitin Shah. Hepatitis A vaccinesPediatric Infectious Disease 2014; 6(2): 72 doi: 10.1016/j.pid.2014.07.006
9
Francisco M. Averhoff, Yury Khudyakov, Noele P. Nelson. Plotkin's Vaccines2018; : 319 doi: 10.1016/B978-0-323-35761-6.00024-9
10
Daniel Shouval, Oren Shibolet. Viral Infections of Humans2023; : 1 doi: 10.1007/978-1-4939-9544-8_17-1
11
Greg J Irving, John Holden, Rongrong Yang, Daniel Pope. Hepatitis A immunisation in persons not previously exposed to hepatitis ACochrane Database of Systematic Reviews 2012;  doi: 10.1002/14651858.CD009051.pub2
12
Kui Xiang, Yuri Kusov, Guan Ying, Wang Yan, Yi Shan, Wu Jinyuan, Yin Na, Zhou Yan, Li Hongjun, Sun Maosheng. A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in MiceViruses 2017; 9(9): 260 doi: 10.3390/v9090260
13
Xi Peng, Jin-Bin Feng, Hong Yan, Yun Zhao, Shi-Liang Wang. Distribution of nitric oxide synthase in stomach myenteric plexus of ratsWorld Journal of Gastroenterology 2001; 7(6): 852-854 doi: 10.3748/wjg.v7.i6.852
14
Johannes Hadem, Michael P. Manns. Liver Immunology2007; : 163 doi: 10.1007/978-1-59745-518-3_14
15
Leonard N. Binn, Stanley M. Lemon. Vaccines: A Biography2010; : 335 doi: 10.1007/978-1-4419-1108-7_19
16
Christoph O. Franck, Luise Fanslau, Andrea Bistrovic Popov, Puneet Tyagi, Ljiljana Fruk. Biopolymer‐based Carriers for DNA Vaccine DesignAngewandte Chemie 2021; 133(24): 13333 doi: 10.1002/ange.202010282
17
Jie Yan, Li-Li Chen, Yong-Liang Lou, Xiao-Zhi Zhong. Investigation of HGV and TTV infection in sera and saliva from non-hepatitis patients with oral diseasesWorld Journal of Gastroenterology 2002; 8(5): 857-862 doi: 10.3748/wjg.v8.i5.857
18
Sameer Rao, J. S. Mao, Salman Motlekar, Zhuang Fangcheng, Ganesh Kadhe. A review of immunogenicity and tolerability of live attenuated Hepatitis A vaccine in childrenHuman Vaccines & Immunotherapeutics 2016; 12(12): 3160 doi: 10.1080/21645515.2016.1216286
19
Daniel Shouval. Viral Infections of Humans2014; : 417 doi: 10.1007/978-1-4899-7448-8_17
20
Li Zhang. Hepatitis A vaccinationHuman Vaccines & Immunotherapeutics 2020; 16(7): 1565 doi: 10.1080/21645515.2020.1769389
21
Annette Martin, Stanley M. Lemon. Hepatitis A Virus: From Discovery to VaccinesHepatology 2006; 43(Supplement 1): S164 doi: 10.1002/hep.21052
22
Christoph O. Franck, Luise Fanslau, Andrea Bistrovic Popov, Puneet Tyagi, Ljiljana Fruk. Biopolymer‐based Carriers for DNA Vaccine DesignAngewandte Chemie International Edition 2021; 60(24): 13225 doi: 10.1002/anie.202010282
23
Monjori Mitra, Nitin Shah, MMA Faridi, Apurba Ghosh, VS Sankaranarayanan, Anju Aggarwal, Suparna Chatterjee, Nisha Bhattacharyya, Ganesh Kadhe, Gaurav Vishnoi, Amey Mane. Long term follow-up study to evaluate immunogenicity and safety of a single dose of live attenuated hepatitis a vaccine in childrenHuman Vaccines & Immunotherapeutics 2015; 11(5): 1147 doi: 10.4161/21645515.2014.979646